clinical trials - what actually matters when you're picking one with pleural meso

I'm actually in a different boat with peritoneal instead of pleural, but I've been deep in the trial research since my November diagnosis so maybe some of this translates. Stage and histology absolutely matter. Most trials are pretty specific about what they'll accept, so a stage II pleural trial might not even let me in because I'm peritoneal. When you're looking at trial protocols they usually have like a whole section on inclusion/exclusion criteria and that's where you find out if you're even eligible. I've seen some trials that want stage I-II only, others that go up to stage IV. The biphasic versus epithelioid thing does matter to them even though it shouldn't feel like it should, if that makes sense.

Location is the thing I keep wrestling with. I'm in Cleveland and there's a facility here running a HIPEC trial but I've also been looking at Mayo in Rochester and MD Anderson down in Houston because their trial protocols looked more promising for my specific situation. My oncologist was honest with me in September when I first started looking around, she said "the drug matters but so does the team running it." I ended up requesting my pathology slides from Johns-Manville records just to have them ready to send out for second opinions because some places want to review your own tissue samples before they'll take you on.

I'd get the actual protocol documents for any trial you're considering. Not just the summary, the full thing. I keep a spreadsheet with the drugs being tested, the phase, the primary endpoint they're measuring, and whether it's combination therapy or single agent. Might sound obsessive but when you're making this decision you want to know if they're testing immunotherapy or chemotherapy or something completely different.

Don't let location be the only factor though. Closer isn't always better if the trial itself isn't designed well.

My dad's been on palliative care since October but we spent months before that looking at trials, and honestly the thing nobody told us upfront is that eligibility criteria are way more restrictive than you'd think. Stage II pleural is actually pretty desirable for a lot of protocols because you've already had surgery, so you're not comparing apples to oranges with people who haven't, but that also means some trials specifically exclude post-surgical patients. We called three different centers and only one was even taking new enrollees in his histology subtype.

The location piece is real. We looked at Northwestern here in Chicago because it's close, but they had a six month waitlist in early 2025. Instead we ended up at Mayo Rochester because their trial coordinator called us back the same day and had an opening. The tradeoff was travel, yeah, but Mayo handled a lot of it through their patient navigation program. So it wasn't really about which trial was "better" in a vacuum, it was which one could actually take him and when.

One oddly specific thing that mattered to us: ask about the biopsy requirement. One trial wanted another tissue sample and my dad was absolutely done with procedures at that point. Another only needed imaging. That detail killed one option for us immediately even though the drug they were testing sounded promising. So when you're talking to the oncologist, get the actual protocol, not just the summary. Ask about the tissue work, the scan schedule, whether it's inpatient or outpatient visits. Stage matters way more than location, but logistics matter more than you think.

Had my pleurectomy at the VA here in Norfolk back in August so I'm right there with you. My oncologist at the VA brought up trials too and yeah, it's a lot of noise to sort through.

Stage and cell type absolutely matter. Pleural is what we've got, so peritoneal and biphasic trials won't touch you. That narrows things down right there. Stage II also limits some of the trials because they want specific populations. I looked at maybe four or five that were actually open to my profile and location wasn't a dealbreaker for most of them.

What I focused on was which ones had already moved past the early phase stuff. Phase 1 trials you're basically a test dummy and that didn't sit right with me. Phase 2 and 3 meant they'd already seen some data. My oncologist M. at the VA was straight with me about which ones had better track records with pleural cases specifically. That mattered more than the hospital's name honestly. I had a buddy recommend Johns Hopkins but the trial there wanted people who hadn't had surgery yet and that ship had sailed for me.

Location does factor in but not how you think. I could've done one up in Baltimore but every other week driving north on 64 for two years sounded like a grind. Found one through Eastern Virginia Medical School that was running a trial with less frequent visits once you stabilize. That's the one I went with. Started 0900 hours in October. The actual drug matters less than you'd think compared to the support structure around it. Make sure they have good people handling side effects and the coordinators are responsive. You'll know pretty quick if a place is disorganized and you don't want to find that out six months in.

Get your oncologist's honest take on which trials have data backing them up. Don't pick based on what sounds coolest.

Look, I'm gonna be blunt because that's what helped me. The VA oncologist will tell you stage and histology matter, and yeah they do, but what nobody really emphasizes is that you need to ask about the trial's endpoints upstairs. Are they measuring response rate or overall survival or quality of life metrics? Because some trials are just trying to prove the drug doesn't kill you faster, not that it actually helps. I spent weeks looking at stuff online after my December surgery and got caught up in the flashy language around "novel immunotherapy" or whatever, but when I actually sat down with the trial coordinator at Balboa Naval Medical Center, she walked me through what they were actually tracking and it was different than what the marketing material made it sound like. Also ask point blank about dropout rates and whether people are finishing the full protocol. A trial that looks good on paper means nothing if half the guys are too sick to keep going by month three. And yeah, location matters because you don't want to be driving when you're running on chemo and recovering from surgery. I'm staying local for that exact reason, even if there's a "better" trial a few hours away. You're not overthinking it.

Joe's been on an immunotherapy trial since November and honestly the thing that made the biggest difference for us was asking about the follow-up schedule before we committed to anything. Like, one trial wanted him at Duke every single week for labs and imaging, another one at Moffitt was every other week but required overnight stays because of the infusion timing. We ended up going with Moffitt even though it's further from Tampa because the rhythm just worked better with his energy levels and honestly my teaching instincts kicked in here - you gotta look at the actual day-to-day structure, not just what drug they're testing. The epithelioid versus biphasic thing matters for eligibility like Amy said, but what I didn't expect was how much the logistics would matter for whether you can actually stick with it. Have you asked your oncologist about what a typical week or month actually looks like for each trial you're considering?

I'm peritoneal not pleural so different beast, but yeah the histology absolutely matters for trial eligibility - most trials are pretty specific about what type they'll take. Definitely ask your oncologist which trials are even open to stage II pleural candidates in your area first, that'll narrow things down fast instead of chasing stuff you don't qualify for anyway.